Delayed treatment effects, treatment switching and heterogeneous patient populations: How to design and analyze RCTs in oncology (Q108613): Difference between revisions
From MaRDI portal
Removed claim: author (P16): Item:Q108887 |
Normalize DOI. |
||
| (7 intermediate revisions by 7 users not shown) | |||
| Property / DOI | |||
| Property / DOI: 10.1002/pst.2062 / rank | |||
| Property / author | |||
| Property / author: Nicolás M. Ballarini / rank | |||
Normal rank | |||
| Property / MaRDI profile type | |||
| Property / MaRDI profile type: MaRDI publication profile / rank | |||
Normal rank | |||
| Property / Wikidata QID | |||
| Property / Wikidata QID: Q98647497 / rank | |||
Normal rank | |||
| Property / DOI | |||
| Property / DOI: 10.1002/PST.2062 / rank | |||
Normal rank | |||
| links / mardi / name | links / mardi / name | ||
Latest revision as of 21:11, 27 December 2024
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Delayed treatment effects, treatment switching and heterogeneous patient populations: How to design and analyze RCTs in oncology |
scientific article |
Statements
20
0 references
1
0 references
129-145
0 references
23 August 2020
0 references
